Piper Sandler Downgrades Cara Therapeutics (CARA) to Neutral

November 14, 2023 12:59 AM EST Send to a Friend
Piper Sandler analyst David Amsellem downgraded Cara Therapeutics (NASDAQ: CARA) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login